Memorial Sloan Kettering Curbs Executives’ Ties to Industry After Conflict-of-Interest Scandals
This article was reported and written in collaboration with ProPublica, the nonprofit journalism organization. Memorial Sloan Kettering Cancer Center, one of the world’s leading research institutions, announced on Friday that it would bar its top executives from serving on corporate boards of drug and health care companies that, in some cases, had paid them hundreds…